Ignite Creation Date:
2024-05-06 @ 1:08 AM
Last Modification Date:
2024-10-26 @ 11:00 AM
Study NCT ID:
NCT01743898
Status:
COMPLETED
Last Update Posted:
2014-08-04
First Post:
2012-10-07
Brief Title:
A Prospective Pharmacodynamic Study of Rivaroxaban
Sponsor:
University of North Carolina Chapel Hill
Organization:
University of North Carolina Chapel Hill
Organization Data
Organization:
University of North Carolina Chapel Hill
Class:
OTHER
Study ID:
12-1254
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of North Carolina Chapel Hill
Lead Sponsor Class:
OTHER
Responsible Party:
Suzanne J Francart PharmD CPP
Responsible Party Title:
Pharm D CPP
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of North Carolina Chapel Hill
Old Name:
None
Old Organization:
None